These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 2804591)
1. Platelet aggregability after endoscopic intravariceal injection of 5 per cent ethanolamine oleate into oesophageal varices. Yamaga H; Hashizume M; Kitano S; Higashi H; Sugimachi K Br J Surg; 1989 Sep; 76(9):939-42. PubMed ID: 2804591 [TBL] [Abstract][Full Text] [Related]
2. Mechanism of the haemostatic effect of ethanolamine oleate in the injection sclerotherapy for oesophageal varices. Kang JH; Kambayashi J; Sakon M; Shiozaki H; Ogawa Y; Ohshiro T; Mori T Br J Surg; 1987 Jan; 74(1):50-3. PubMed ID: 3828735 [TBL] [Abstract][Full Text] [Related]
3. Platelet aggregability and prostacyclin/thromboxane A2 ratio after endoscopic injection sclerotherapy with different sclerosants. Yamaga H; Hashizume M; Wada H; Kitano S; Sugimachi K Eur Surg Res; 1991; 23(3-4):228-34. PubMed ID: 1782968 [TBL] [Abstract][Full Text] [Related]
4. Human thrombin plus 5 per cent ethanolamine oleate injected to sclerose oesophageal varices: a prospective randomized trial. Kitano S; Hashizume M; Yamaga H; Wada H; Iso Y; Iwanaga T; Sugimachi K Br J Surg; 1989 Jul; 76(7):715-8. PubMed ID: 2765808 [TBL] [Abstract][Full Text] [Related]
5. Trial of sclerosing agents in patients with oesophageal varices. Kitano S; Iso Y; Yamaga H; Hashizume M; Higashi H; Sugimachi K Br J Surg; 1988 Aug; 75(8):751-3. PubMed ID: 3048533 [TBL] [Abstract][Full Text] [Related]
6. Hypercoagulopathy after repeated injection of 5% ethanolamine oleate to sclerose esophageal varices. Hashizume M; Yamaga H; Kitano S; Sugimachi K Hepatogastroenterology; 1990 Dec; 37(6):565-8. PubMed ID: 2289769 [TBL] [Abstract][Full Text] [Related]
7. Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% polidocanol for sclerosing esophageal varices. Kitano S; Wada H; Tanoue K; Hashizume M; Koyanagi N; Sugimachi K Hepatogastroenterology; 1992 Dec; 39(6):546-8. PubMed ID: 1483669 [TBL] [Abstract][Full Text] [Related]
8. Transvenous sclerotherapy for huge oesophagogastric varices using open injection sclerotherapy. Kitano S; Baatar D; Bandoh T; Yoshida T; Tsuboi S; Matsumoto T Br J Surg; 2000 Jul; 87(7):926-30. PubMed ID: 10931030 [TBL] [Abstract][Full Text] [Related]
9. Study on coagulation profile of patients with cirrhosis of the liver undergoing elective fibreoptic injection sclerotherapy of oesophageal varices. Bernardi M; Palareti G; Pini P; Caletti GC; Brocchi E; Gasbarrini G Hepatogastroenterology; 1984 Jun; 31(3):125-8. PubMed ID: 6469201 [TBL] [Abstract][Full Text] [Related]
10. Injection sclerotherapy for gastric varices using N-butyl-2-cyanoacrylate and ethanolamine oleate. Miyazaki S; Yoshida T; Harada T; Shigemitsu T; Takeo Y; Okita K Hepatogastroenterology; 1998; 45(22):1155-8. PubMed ID: 9756025 [TBL] [Abstract][Full Text] [Related]
12. Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study. Oho K; Iwao T; Sumino M; Toyonaga A; Tanikawa K Endoscopy; 1995 Jun; 27(5):349-54. PubMed ID: 7588347 [TBL] [Abstract][Full Text] [Related]
13. A sclerosant with astringent properties developed in China for oesophageal varices: comparison with ethanolamine oleate and polidocanol. Nishida R; Inoue R; Takimoto Y; Kita T J Gastroenterol Hepatol; 1999 May; 14(5):481-8. PubMed ID: 10355514 [TBL] [Abstract][Full Text] [Related]
14. A comparative study of 50% alcohol and ethanolamine oleate for oesophageal sclerotherapy. Vij JC; Kumar N; Kumar A; Anand BS; Broor SL Indian J Gastroenterol; 1988 Oct; 7(4):211-3. PubMed ID: 3053436 [No Abstract] [Full Text] [Related]
15. Systemic dissemination of ethanolamine oleate after injection sclerotherapy for esophageal varices. Sukigara M; Omoto R; Miyamae T Arch Surg; 1985 Jul; 120(7):833-6. PubMed ID: 2990382 [TBL] [Abstract][Full Text] [Related]
16. Endoscopic sclerotherapy of oesophageal varices due to hepatosplenic schistosomiasis. A randomized controlled trial evaluating effect of sclerosant concentration. Dowidar N; Hafez A J Egypt Soc Parasitol; 2002 Aug; 32(2):537-49. PubMed ID: 12214931 [TBL] [Abstract][Full Text] [Related]
17. [Ethanolamine oleate as a sclerosing solution in the therapy of esophageal varices]. Tsutsumi M; Takada A Nihon Rinsho; 1990 Apr; 48(4):713-7. PubMed ID: 2366357 [No Abstract] [Full Text] [Related]
18. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation. Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196 [TBL] [Abstract][Full Text] [Related]
19. The value of combined use of N-butyl-2-cyanoacrylate and ethanolamine oleate in the management of bleeding esophagogastric varices. Thakeb F; Salama Z; Salama H; Abdel Raouf T; Abdel Kader S; Abdel Hamid H Endoscopy; 1995 Jun; 27(5):358-64. PubMed ID: 7588349 [TBL] [Abstract][Full Text] [Related]
20. A prospective randomized study comparing the effects of large and small volumes of the sclerosant 5% ethanolamine oleate injected into esophageal varices. Iso Y; Kitano S; Iwanaga T; Koyanagi N; Sugimachi K Endoscopy; 1988 Nov; 20(6):285-8. PubMed ID: 3229387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]